🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

16 recruiting trials

for Asthma; Eosinophilic

Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils NCT04538937n/a1 site📍 Innsbruck Medical University Innsbruck · Tests: no intervention Depemokimab Asthma Imaging and Bronchoscopy Sub-Study NCT06979323Phase 350 sites📍 Brooksville📍 Plantation📍 Kansas City GlaxoSmithKline · Tests: Depemokimab European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank NCT02852928n/a3 sites📍 Hanover📍 Ankara📍 Edinburgh Matthias Griese A Study of Depemokimab in Participants of 6 to 11 Years of Age NCT07671001Phase 33 sites📍 Mobile📍 Colorado Springs📍 Watertown GlaxoSmithKline · Tests: Depemokimab Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study NCT02947945Phase 21 site📍 Denver National Jewish Health · Tests: Reslizumab A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy NCT07214753n/a28 sites📍 Salerno📍 Padova📍 Teramo AstraZeneca · Tests: benralizumab Real Life Study of Biologicals in Patients With Severe CRSwNP NCT05938972n/a1 site📍 Ghent University Hospital, Ghent · Tests: Mepolizumab A Non-interventional, Prospective Study With Benralizumab NCT06422078n/a41 sites📍 Ahrensburg📍 Ansbach📍 Aschaffenburg AstraZeneca Predictive Signature of Benralizumab Response NCT04565483Phase 420 sites📍 Aix-en-Provence📍 Angers📍 Bordeaux Nantes University Hospital · Tests: Benralizumab Prefilled Syringe Efficacy and Safety Study of 610 in Patients With Severe Asthma NCT06323213Phase 31 site📍 Shanghai Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Tests: 610, Placebo Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment NCT07444567Phase 346 sites📍 Aurora📍 Bethesda📍 Ann Arbor AstraZeneca · Tests: Benralizumab Therapeutic Relevance of Abnormal Airway Morphology in Asthma NCT06970080Phase 42 sites📍 Hamilton📍 London McMaster University · Tests: Inhaled corticosteroid (ICS), Oral Corticosteroid (OCS) A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients NCT06441812Phase 21 site📍 Chengdu Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: SHR-1703 Injection Allergy and Immunology Natural History Study NCT05584488n/a1 site📍 New York Columbia University A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma NCT07323654Phase 281 sites📍 Lancaster📍 Long Beach📍 Northridge Kymera Therapeutics, Inc. · Tests: KT-621, Placebo This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab NCT06862206n/a36 sites📍 Anhui📍 Anning📍 Beijing AstraZeneca · Tests: benralizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy